Dermata Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Dermata Therapeutics Total Assets Growth & History (DRMA)
Dermata Therapeutics's total assets was $7.9M for fiscal 2025.
View full Dermata Therapeutics company overviewDermata Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.9M | $4.3M | +122.53% |
| 2024 | 2024-12-31 | $3.5M | −$4.4M | −55.71% |
| 2023 | 2023-12-31 | $8.0M | $1.0M | +14.89% |
| 2022 | 2022-12-31 | $6.9M | −$4.7M | −40.26% |
| 2021 | 2021-12-31 | $11.6M | $11.0M | +1819.87% |
| 2020 | 2020-12-31 | $605,453 | — | — |
Dermata Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.3M | −$1.3M | −19.87% |
| Q1 2026 | 2026-03-31 | $7.5M | −$2.5M | −25.38% |
| Q4 2025 | 2025-12-31 | $7.9M | $4.3M | +122.53% |
| Q3 2025 | 2025-09-30 | $5.1M | −$1.6M | −24.16% |
| Q2 2025 | 2025-06-30 | $6.6M | $1.4M | +26.81% |
| Q1 2025 | 2025-03-31 | $10.0M | $4.8M | +93.16% |
| Q4 2024 | 2024-12-31 | $3.5M | −$4.4M | −55.71% |
| Q3 2024 | 2024-09-30 | $6.7M | −$636,039 | −8.69% |
| Q2 2024 | 2024-06-30 | $5.2M | −$3.5M | −39.90% |
| Q1 2024 | 2024-03-31 | $5.2M | −$4.1M | −44.27% |
| Q4 2023 | 2023-12-31 | $8.0M | $1.0M | +14.89% |
| Q3 2023 | 2023-09-30 | $7.3M | −$1.7M | −18.40% |
| Q2 2023 | 2023-06-30 | $8.7M | −$2.3M | −20.98% |
| Q1 2023 | 2023-03-31 | $9.3M | $251,090 | +2.78% |
| Q4 2022 | 2022-12-31 | $6.9M | −$4.7M | −40.26% |
| Q3 2022 | 2022-09-30 | $9.0M | −$4.7M | −34.42% |
| Q2 2022 | 2022-06-30 | $11.0M | $9.9M | +869.90% |
| Q1 2022 | 2022-03-31 | $9.0M | — | — |
| Q4 2021 | 2021-12-31 | $11.6M | $11.0M | +1819.87% |
| Q3 2021 | 2021-09-30 | $13.7M | — | — |
| Q2 2021 | 2021-06-30 | $1.1M | — | — |
| Q4 2020 | 2020-12-31 | $605,453 | — | — |
Dermata Therapeutics total assets trends
Over the last five fiscal years, Dermata Therapeutics's total assets increased from $605,453 to $7.9M, a change of $7.3M. The latest reported quarter, Q2 2026, shows $5.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dermata Therapeutics source filings ↗